Champions Oncology, Inc. - Laporan Laba Rugi (TTM)

Champions Oncology, Inc.
US ˙ NasdaqCM ˙ US15870P3073

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Champions Oncology, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
10-31
2021
01-31
2021
04-30
2021
07-31
2021
10-31
2022
01-31
2022
04-30
2022
07-31
2022
10-31
2023
01-31
2023
04-30
2023
07-31
2023
10-31
2024
01-31
2024
04-30
2024
07-31
2024
10-31
2025
01-31
2025
04-30
Revenue 37 39 41 43 44 47 49 52 54 54 54 53 50 49 50 52 54 59 57
Change (%) 4.81 4.63 4.16 3.90 5.36 4.94 5.07 4.84 -0.78 0.36 -2.20 -5.14 -1.51 1.89 2.99 3.71 9.37 -2.81
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 20 21 21 22 21 23 24 25 27 28 30 30 29 29 29 29 30 28 28
Change (%) 1.46 3.88 0.28 -0.16 8.30 1.63 7.01 7.25 4.77 3.93 2.14 -2.74 0.51 -0.30 -2.08 2.81 -4.16 0.07
% of Revenue 54.37 52.63 52.26 50.31 48.34 49.69 48.12 49.01 50.14 52.94 54.82 57.25 58.70 59.91 58.62 55.73 55.25 48.42 49.85
Gross Operating Profit 17 19 20 21 23 24 25 26 27 25 24 23 21 20 21 23 24 30 29
Change (%) 8.79 5.46 8.40 8.02 2.61 8.22 3.28 2.51 -6.35 -3.65 -7.46 -8.36 -4.38 5.16 10.18 4.84 26.08 -5.52
% of Revenue 45.63 47.37 47.74 49.69 51.66 50.31 51.88 50.99 49.86 47.06 45.18 42.75 41.30 40.09 41.38 44.27 44.75 51.58 50.15
SG&A 12 12 12 13 14 14 15 16 16 17 17 18 18 18 18 18 17 17 17
Change (%) 3.91 -2.31 9.46 6.07 3.21 7.48 2.34 3.86 3.36 1.29 3.17 0.94 1.29 -0.31 -2.37 -4.27 -2.12 1.79
% of Revenue 31.67 31.40 29.32 30.81 31.45 30.81 31.55 30.73 30.45 31.71 32.01 33.76 35.93 36.95 36.15 34.27 31.63 28.31 29.65
R&D 6 7 7 8 9 9 9 10 10 11 12 11 11 10 10 8 7 7 7
Change (%) 7.54 3.64 9.82 8.21 3.53 5.87 6.22 3.06 9.96 2.31 -0.81 -0.78 -8.94 -7.75 -14.03 -10.07 -6.33 -1.26
% of Revenue 17.25 17.70 17.53 18.49 19.25 18.92 19.09 19.30 18.97 21.02 21.43 21.73 22.73 21.02 19.03 15.88 13.77 11.80 11.99
OpEx 39 40 41 43 44 47 49 51 54 57 58 59 59 58 57 55 54 52 52
Change (%) 3.23 1.93 4.68 3.32 5.76 4.25 5.36 5.38 5.33 2.82 1.86 -1.26 -1.08 -1.63 -4.17 -1.41 -3.81 0.45
% of Revenue 103.29 101.74 99.11 99.61 99.05 99.42 98.76 99.03 99.55 105.67 108.26 112.75 117.37 117.88 113.80 105.89 100.66 88.52 91.49
Operating Income -1 -1 0 0 0 0 1 0 0 -3 -4 -7 -9 -9 -7 -3 -0 7 5
Change (%) -44.72 -153.74 -54.37 153.29 -36.17 124.81 -17.96 -51.41 -1,358.68 46.06 50.98 29.21 1.38 -21.34 -56.08 -88.39 -2,004.82 -27.93
% of Revenue -3.29 -1.74 0.89 0.39 0.95 0.58 1.24 0.97 0.45 -5.67 -8.26 -12.75 -17.37 -17.88 -13.80 -5.89 -0.66 11.48 8.51
Interest Expense -0 -0 -0 -0 -0
Change (%) -0.00 -0.00 -0.00 -3.57
% of Revenue -0.06 -0.05 -0.05 -0.05 -0.05
Net Income -2 -1 0 0 0 0 1 0 0 -3 -5 -8 -10 -10 -7 -3 -1 6 5
Change (%) -32.86 -132.04 -68.23 240.00 -43.99 150.23 -26.82 -73.07 -2,987.04 71.10 42.12 27.10 0.94 -25.21 -53.31 -82.40 -1,174.75 -26.86
% of Revenue -4.50 -2.88 0.88 0.27 0.88 0.47 1.12 0.78 0.20 -5.81 -9.90 -14.39 -19.28 -19.76 -14.51 -6.58 -1.12 10.97 8.26

Source: Capital IQ

Other Listings
DE:2I3 € 5.65
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista